# Real-world Patient Characteristics, Treatment Patterns, and Healthcare Utilization Among KarXT Users

> **NCT07571148** · — · ACTIVE_NOT_RECRUITING · sponsor: **Bristol-Myers Squibb** · enrollment: 6876 (actual)

## Conditions studied

- Schizophrenia

## Interventions

- **DRUG:** KarXT (xanomeline and trospium)

## Key facts

- **NCT ID:** NCT07571148
- **Lead sponsor:** Bristol-Myers Squibb
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2026-01-16
- **Primary completion:** 2026-03-25
- **Final completion:** 2026-07-31
- **Target enrollment:** 6876 (ACTUAL)
- **Last updated:** 2026-05-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07571148

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07571148, "Real-world Patient Characteristics, Treatment Patterns, and Healthcare Utilization Among KarXT Users". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT07571148. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*